Document is current
Any future updates will be listed below
-
Authors
Guyton, John R. https://orcid.org/0000-0003-0224-7923
Boden, William E. https://orcid.org/0000-0001-7145-8084
- License Information
-
More Information
Article History
Received: 26 February 2024
Accepted: 30 July 2024
First Online: 5 September 2024
Competing interests
: J.R.G. declares no competing interests. W.E.B. served on the executive steering committee for the TRAVERSE trial, funded by AbbVie, and has received research grant support from AbbVie. In the past, both authors received institutional support from the AIM-HIGH trial funded by the US National Institutes of Health (NIH), and W.E.B. served as principal investigator of AIM-HIGH.
